TIM-3 as a potential exhaustion marker in CD4+ T cells of COVID-19 patients

28Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: COVID-19 causes a range of clinical symptoms from mild to critical and can be life-threatening. Up to now, it has led to many deaths. We aimed to evaluate exhausted markers on CD4+ T cells of COVID-19 patients. Methods: In this study, we evaluated 44 patients with confirmed COVID-19 disease and 16 healthy individuals. Patients were divided into moderate/severe and critical groups. Peripheral blood mononuclear cells (PBMCs) were isolated and stained by anti-human CD39, PD-1, TIM-3, and anti-human CD4. The percentage of each CD4+ subpopulation was calculated by flow cytometry. Furthermore, we collected clinical information and laboratory data of both control and patient groups. Results: We detected overexpression of TIM-3 on CD4+ T cells in both critical and moderate/severe patients than in healthy individuals (HIs; p

Author supplied keywords

Cite

CITATION STYLE

APA

Modabber, Z., Shahbazi, M., Akbari, R., Bagherzadeh, M., Firouzjahi, A., & Mohammadnia-Afrouzi, M. (2021). TIM-3 as a potential exhaustion marker in CD4+ T cells of COVID-19 patients. Immunity, Inflammation and Disease, 9(4), 1707–1715. https://doi.org/10.1002/iid3.526

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free